FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely pediatrics and can be used to treat attention deficit and hyperkinetic behavior syndrome (ADHBS) of moderate severity in patients aged 6 to 12 years. To do this, ethylmethylhydroxypyridine succinate is administered orally, 125 mg 2 times a day in the afternoon and evening for 6-8 weeks.
EFFECT: method provides an increase in the effectiveness of treatment of moderate ADHBS in this category of patients due to a selected dose of ethylmethylhydroxypyridine succinate in a certain developed regimen.
1 cl, 6 ex, 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| MODULATION sAPP, sAPPα AND BDNF LEVELS IN INDIVIDUALS DIAGNOSED WITH FXS AND ASD | 2013 |
|
RU2675252C2 |
| THERAPEUTIC AGENT FOR TREATING NEUROLOGICAL BEHAVIOUR DISORDERS AND METHOD OF TREATING NEUROLOGICAL BEHAVIOUR DEVELOPMENT DISORDERS | 2011 |
|
RU2536230C2 |
| MEDICATION FOR TREATING ATTENTION DEFICIT DISORDER AND METHOD OF TREATING ATTENTION DEFICIT DISORDER | 2010 |
|
RU2519695C2 |
| METHOD FOR DIAGNOSING THE SEVERITY OF FUNCTIONAL DISORDERS OF THE GASTROINTESTINAL TRACT | 2017 |
|
RU2688308C2 |
| METHOD FOR PREDICTING THERAPEUTIC EFFICACY OF APHOBAZOLUM ANXIOLYTIC IN PATIENTS WITH ANXIETY DISORDERS | 2019 |
|
RU2736391C1 |
| METHODS OF TREATING BEHAVIORAL SYMPTOMS OF NEUROLOGICAL AND MENTAL DISORDERS | 2013 |
|
RU2654230C2 |
| METHOD OF ESTIMATION OF THE TREATMENT AND DIAGNOSTICS EFFICIENCY OF THE CLINICAL COURSE SEVERITY OF THE GASTROINTESTINAL TRACT FUNCTIONAL DISORDERS | 2016 |
|
RU2655540C2 |
| APPLICATION OF ATOMOXETINE HYDROCHLORIDE, PULSE LOW-INTENSITY ELECTROMAGNETIC FIELD AND OXYGEN COCKTAIL IN CHILDREN WITH MINIMAL BRAIN DYSFUNCTION ASSOCIATING HYPERACTIVITY | 2009 |
|
RU2428226C1 |
| ANTIDEPRESSIVE THERAPY | 2008 |
|
RU2379035C1 |
| METHOD OF TREATING HYPERKINETIC DISORDER IN CHILDREN | 2011 |
|
RU2476250C1 |
